These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 6389125

  • 1. In vitro activity of imipenem--a review.
    Braveny I.
    Eur J Clin Microbiol; 1984 Oct; 3(5):456-62. PubMed ID: 6389125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    Neu HC, Chin NX, Labthavikul P.
    J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
    [Abstract] [Full Text] [Related]

  • 4. Activity of imipenem on aerobic bacteria.
    Acar JF, Goldstein FW, Kitzis MD, Gutmann L.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():37-45. PubMed ID: 6421793
    [Abstract] [Full Text] [Related]

  • 5. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Carbapenems: special properties contributing to their activity.
    Neu HC.
    Am J Med; 1985 Jun 07; 78(6A):33-40. PubMed ID: 3873871
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
    Edwards JR, Turner PJ, Wannop C, Withnell ES, Grindey AJ, Nairn K.
    Antimicrob Agents Chemother; 1989 Feb 07; 33(2):215-22. PubMed ID: 2655530
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Review of imipenem.
    Park SY, Parker RH.
    Infect Control; 1986 Jun 07; 7(6):333-7. PubMed ID: 3519499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
    Digranes A, Dibb WL, Benonisen E.
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr 07; 91(2):141-4. PubMed ID: 6603093
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of L-627, a new carbapenem.
    Catchpole CR, Wise R, Thornber D, Andrews JM.
    Antimicrob Agents Chemother; 1992 Sep 07; 36(9):1928-34. PubMed ID: 1416883
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Stamm JM, Hanson CW, Chu DT, Bailer R, Vojtko C, Fernandes PB.
    Antimicrob Agents Chemother; 1986 Feb 07; 29(2):193-200. PubMed ID: 3087274
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Vurma-Rapp U, Kayser FH, Barberis-Maino L.
    J Antimicrob Chemother; 1986 Dec 07; 18 Suppl E():27-33. PubMed ID: 3102452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.